Alerta De Seguridad para HomeChoice PRO Automated Peritoneal Dialysis (PD) System

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por Baxter Healthcare.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2014-03-19
  • Fecha de publicación del evento
    2014-03-19
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: baxter homechoice pro automated peritoneal dialysis (pd) system the australia therapeutic goods administration (tga) posted a medical device safety alert concerning homechoice pro automated peritoneal dialysis (pd) system with product code r5c8320, manufactured by baxter healthcare. the manufacturer is implementing additional warning in homechoice/homechoice pro device product labelling related to patients more vulnerable to unintended increased intraperitoneal volume (iipv), also known as overfill. specific populations using pd therapy including neonates, infants, small children and any patient with significant heart or lung disease are more vulnerable to the negative effects of excessive retention of fluid in the peritoneal cavity that may be related to their dialysis therapy. overfilling with dialysate (iipv) or not draining enough fluid during pd therapy can result in excess fluid in the abdomen accompanied by patient symptoms. the manufacturer has contacted the suppliers (primarily hospitals) of homechoice pro automated peritoneal dialysis units to provide further information about the recall for product correction and instructions to contact affected patients. the manufacturer also advises customers that if unintended increased intraperitoneal volume (overfill) is suspected, they should immediately initiate a manual drain and contact their treating health professional. for details, please refer to tga websites:http://www.Tga.Gov.Au/sara/arn-detail.Aspx?k=rc-2014-rn-00304-1 and http://www.Tga.Gov.Au/safety/alerts-device-automated-peritoneal-dialysis-system-140318.Htm if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 19 march 2014.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: Baxter HomeChoice PRO Automated Peritoneal Dialysis (PD) System
  • Manufacturer

Manufacturer